JC

Judy H. Chiao

Merck: 6 patents #1,819 of 9,382Top 20%
CL Cyclacel Limited: 5 patents #7 of 83Top 9%
SR Sloan Kettering Institute For Cancer Research: 3 patents #138 of 644Top 25%
📍 Berkeley Heights, NJ: #157 of 1,035 inventorsTop 20%
🗺 New Jersey: #8,044 of 69,400 inventorsTop 15%
Overall (All Time): #457,223 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
10226478 Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia 2019-03-12
9872874 Dosage regimen for sapacitabine and seliciclib David R. Blake, Daniella Zheleva, Susan B. Davis, Simon Green, Geoffrey I. Shapiro 2018-01-23
9675631 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine 2017-06-13
8536188 Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine 2013-09-17
8124593 Methods of treatment using sapacitabine Athos Gianella-Borradori 2012-02-28
8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma Victoria M. Richon, William Kevin Kelly, Thomas A. Miller 2011-11-29
7732490 Methods of treating cancer Victoria M. Richon, William Kevin Kelly, Thomas A. Miller 2010-06-08
7456219 Polymorphs of suberoylanilide hydroxamic acid Thomas A. Miller, Victoria M. Richon 2008-11-25
7399787 Methods of treating cancer with HDAC inhibitors Nicholas Bacopoulos, Thomas A. Miller, Carolyn Paradise, Victoria M. Richon 2008-07-15
7375137 Methods of treating cancer with HDAC inhibitors Nicholas Bacopoulos, Thomas A. Miller, Carolyn Paradise, Victoria M. Richon 2008-05-20
7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid Nicholas Bacopoulos, Thomas A. Miller, Carolyn Paradise, Victoria M. Richon 2006-12-12